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retinal photoreceptors and other neuron populations that degenerate in pcdmice. A functional zinc-bind-
ing domain is crucial for Nna1 to support neuron survival.
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A number of neurological disease mutations produce a com-
bined cerebellar degeneration and retinal degeneration phenotype
in affected human patients. An understanding of the genetic and
molecular basis of such phenotypes has been aided by the study
of spontaneous mouse mutants that exhibit similar phenotypes.
The Purkinje cell degeneration (pcd) mouse is an autosomal reces-
sive combined cerebellar—retinal degeneration mutant that arose
spontaneously in 1976 in the C57BR/cdJ strain at the Jackson Lab-
oratory (http://www.jax.org). The original spontaneous mouse
mutant—known as pcd1J—displays moderate gait ataxia by the time
of weaning, which progresses to a profound ataxia by adulthood.
Histological studies have shown that pcd1J mice exhibit normal
development of the cerebellum, as the cerebellum looks grossly
normal at the light microscope level with the expected cytoarchi-
tecture of Purkinje cells separating granule cells and the molecular
layer at postnatal day 15 (P15), Mullen, Eicher, and Sidman (1976).
However, soon thereafter, a sudden and dramatic Purkinje cell
degeneration begins, yielding a progressive near-total loss of cere-
bellar Purkinje cells by P35. Although pcd1J mice are profoundly
ataxic throughout their entire lives, they have normal life spans.ll rights reserved.
a Spada).The pcd locus has experienced a number of re-mutations, as six dif-
ferent pcd alleles have arisen (1J, 2J, 3J, 5J, 6J, and 7J), and one
transgene insertion allele (pcdJWG) has occurred (http://www.
informatics.jax.org/searches/allele_report.cgi?_Marker_key=79447).
Most of the pcd alleles, including 1J, 3J, and 5J, yield interchange-
ably severe phenotypes, while certain pcd alleles, such as 2J, are
hypo-morphs, preserve some expression, and thus result in milder
phenotypes (http://www.informatics.jax.org/searches/allele_report.
cgi?_Marker_key=79447).
The other hallmark feature described in pcd mutant mice are a
progressive form of retinal degeneration, culminating in marked
drop-out of photoreceptors and thinning of the outer segment re-
gion before 1 year of age, LaVail, Blanks, and Mullen (1982).
Although the retinal degeneration unfolds over a much longer time
frame than the rapid Purkinje cell degeneration from which pcd
gets its name, signs of retinal degeneration do become apparent
as early as P25, and frequent pyknotic photoreceptor nuclei to-
gether with notable outer segment thinning can be documented
by P60, Blanks, Mullen, and LaVail (1982). Loss of photoreceptor
nuclei and thinning of the outer nuclear layer of the retina are
obvious by 6 months of age. While the outer plexiform layer exhib-
its thinning, neither the inner nuclear layer nor the inner plexiform
layer are signiﬁcantly affected, LaVail et al. (1982). Ultrastructural
analysis of pcd retinal degeneration has indicated that photorecep-
tor degeneration is the principal feature of the retinal phenotype in
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involving the inner segments of photoreceptors3. In addition to
retinal and cerebellar degeneration, pcdmice also exhibit degener-
ation of thalamic neurons from P50 and P60, gradual loss of mitral
neurons in the olfactory bulb during the ﬁrst year of life, and male
infertility, Mullen et al. (1976), O’Gorman and Sidman (1985),
O’Gorman (1985).
After mapping the pcd gene defect to a 1 cM region on mouse
chromosome 13, screening of candidate genes yielded independent
mutations in the Nna1 gene in two pcd strains (2J and 3J), Fernan-
dez-Gonzalez et al. (2002).
Loss of function of the Nna1 gene as the cause of the pcd pheno-
type is further supported by a marked reduction in the level of
Nna1 mRNA and protein expression in the original pcd1J mutant,
Fernandez-Gonzalez et al. (2002), and the discovery of a single
amino acid insertion in the Nna1 coding region in the pcd5J strain
that destabilizes Nna1 protein Chakrabarti et al. (2006). The
Nna1 gene encodes a putative protease—a zinc carboxypeptidase
(ZnCP)—that is highly conserved in various species, ranging from
worms to humans, Harris et al. (2000). In situ hybridization studies
have shown that the pattern of Nna1 expression corresponds to the
pattern of neurodegeneration observed in pcd mutant mice, Harris
et al. (2000). However, Nna1’s ZnCP activity remains to be con-
ﬁrmed and its role in promoting neuronal survival in the cerebel-
lum and retina is still unknown.
Although multiple independent mutant alleles within the
Nna1 gene have been reported in three different pcd strains, Fer-
nandez-Gonzalez et al. (2002), concomitant alteration of the func-
tion of another gene(s) could be contributing to the diverse
neurodegenerative phenotypes observed in pcd mice. To address
this question and to determine which of Nna1’s functional do-
mains account for neuronal survival, we obtained a murine BAC
that contains the entire Nna1 gene with generous DNA regions
ﬂanking the 50 and 30 ends of the Nna1 gene. We produced
Nna1 BAC transgenic mice and demonstrated that restoration of
Nna1 gene expression within the cerebellum and the retina is suf-
ﬁcient to rescue the Purkinje cell degeneration and retinal degen-
eration in pcd mice. We then derived an Nna1 BAC construct with
mutations in the zinc-binding domain of the Nna1 carboxypepti-
dase region to abrogate putative enzymatic activity or any zinc-
binding dependent function.
Expression of zinc-binding deﬁcient Nna1 protein did not
rescue pcd cerebellar or retinal degeneration, implicating ZnCP
enzymatic activity or some other zinc-dependent protein activity
in Nna1’s normal survival function in neurons.
2. Methods
2.1. Generation of BAC mice
A 190-kb BAC (clone RP-23-119N9) containing the Nna1 gene
was released from the vector backbone by NotI digestion and in-
jected into the pronuclei of fertilized eggs. A co-targeting method
of recombineering was utilized to target the H912A–E915A muta-
tions into this BAC 9A 499-bp genomic fragment was ampliﬁed by
PCR (50-ttggtcacgttacagactcctgca-30; 50-aaatcatcaaacccattatttgaat-
taac-30), gel puriﬁed, and co-electroporated with a kanamyacin
resistance gene ﬂanked on both ends by 50 bp GalK targeting se-
quences. The 912/915 mutations (GCT-CCT-GGA-GCA) introduce
a unique MwoI restriction site. Twenty-four kanamycin resistant
clones were screened by PCR using primers that ﬂanked the
499 bp targeting sequence (50-ccaagtggtccctgtgctgtg-30; 50-
aagagtctgacgcattacccac-30) and one of the 24 clones analyzed
yielded the expected MwoI polymorphism. The mutation was con-
ﬁrmed by sequence analysis and the integrity of the BAC clone was
further veriﬁed by PFGE.2.2. Bioinformatics
Functional domain prediction for Nna1 was carried out using
Blastp at NCBI, http://www.ncbi.nlm.nih.gov/blast, and proSITE at
ExPASy, http://au.expasy.org/tools.
2.3. Mouse genotyping
DNA was extracted from 1 cm tail snips and resuspended in
125 |l of low Tris/EDTA. Samples for the real-time PCR standard
curve used DNA from a known pcd5J heterozygous animal. Master
mixes for pcd5J analysis were made up as follows: 12.5 ll of 2
Taqman Universal PCR Master Mix (ABI), 0.225 ll of 100 lM for-
ward primer, 50-TACACCATCACCTTCACCGT-30, 0.225 ll of 100 lM
reverse primer. 50-CACGTACTCGACTCTGCAGG, and 0.05 ll of
100 lm FAM-labeled probe (50-caaggacgacgatgtctgct-30) per reac-
tion. For quantiﬁcation, b-actin was measured using an Assay on
Demand probe and primer set at the recommended dilution
(ABI). For the assay, 5 ll of diluted DNA sample/standard was
added to 20 ll of master mix in a 96-well optical reaction plate
(ABI). We used an ABI 7500 thermal cycler with the following con-
ditions: Stage 1; Reps 1; 50 C; Time 2 min. Stage 2; Reps 1; 95 C;
Time 10 min. Stage 3; Reps 40; 950C; Time 15 s. 60 C; Time 1 min.
Data collection was set to occur at Stage 3–Step 2. Mean quantities
were normalized against b-actin, and pcd5J mean quantity was nor-
malized to b-actin with values obtained for the pcd5J heterozygous
control set to 1. Unknowns were compared to C57BL/6J (wild-
type), pcd5J heterozygous, and pcd5J homozygous controls.
2.4. Behavior and histology analysis
Mice were observed in their cages and were removed for visual
gait analysis for signs of ataxia. For preparation of retinal and cer-
ebellar tissue sections, mice under deep anesthetization were per-
fused transcardially with 4% paraformaldehyde in 0.1 M phosphate
buffer (PBS, pH 7.4). For retinal histology, anterior chambers were
removed and inﬁltrated with JB-4 methacrylate after washing and
dehydration. Sections (5 lm thick) were cut and immersed in 5%
Richardson’s stain. The brain was removed, placed in 4% parafor-
maldehyde for 4 h, and cryoprotected in 10% sucrose and then
30% sucrose in PBS. Parasagittal frozen sections were cut at
50 lm thickness on a cryostat. Immunohistochemistry was per-
formed on free-ﬂoating sections as previously described, Chakrab-
arti et al. (2006).All experiments involving animals were approved
by and performed in accordance with University of Washington IA-
CUC guidelines.
2.5. Western blot analysis
Protein lysates were obtained by homogenizing tissues 1:10
(w/v) in PBS. Equal amounts of homogenate and sample buffer
(62.5 mM Tris–HCl, pH 6.8, 4% SDS, 200 mM dithiothreitol, 10%
glycerol, 0.001% Bromophenol blue) were boiled for 10 min. Pro-
tein samples were resolved by SDS–PAGE transferred to nitrocellu-
lose, and probed with a polyclonal Nna1 antibody at 1:1000,
Chakrabarti et al. (2006). Immunoblots were developed with
HRP-coupled anti-rabbit antibodies at 1:2000 dilution and
Enhanced Chemiluminescence (Amersham).
3. Results
3.1. Generation and characterization of Nna1 BAC transgenic mice
The existence of allelic mutations within the Nna1 gene in
different strains of mice displaying the pcd phenotype has puta-
tively established that Nna1 is the causal gene for pcd, Fernan-
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mutations can affect gene expression and function at considerable
distances, we deemed it necessary to test if transgenic expression
of Nna1 is necessary and sufﬁcient to rescue the principal neurode-
generative features of the pcd phenotype. As standard transgenic
approaches relying upon heterologous promoters cannot accu-
rately recapitulate proper temporal and spatial expression pat-
terns, we chose to pursue a bacterial artiﬁcial chromosome (BAC)
transgenic strategy. This strategy is especially warranted since
the loss of function(s) of the Nna1 gene product that accounts for
the full pcd phenotype is yet to be deﬁned. The Nna1 gene spans
109 kb on mouse chromosome 13. Our survey of available BAC’s
yielded RP23-119N9 as the best candidate for Nna1 transgene
expression, as RP23-119N9 is 181 kb in length, with 45.5 kb of
DNA 50 to the Nna1 transcriptional start site and 28.5 kb of DNA
30 to the last exon of the Nna1 gene (Supplementary Fig. 1). Based
upon the current annotation of this region, no other genes are pre-
dicted within BAC RP23-119N9 http://genome.ucsc.edu/. The se-
quence preceding the transcriptional start site of Nna1 contains
two predicted CpG islands http://genome.ucsc.edu/.
Of these two CpG islands, the CpG island adjacent to the start
site of transcription is 1 kb in length with 118 CpG dyads (Sup-
plementary Fig. 1), suggesting that key regulatory sequences for
Nna1 gene expression are contained within this BAC clone.
Using BAC isolation techniques commonly employed by our
group, Hegde and Paulson (2004), Sopher and La Spada (2006),
we generated two Nna1transgenic founders, which were desig-
nated as Nna1-WT1 and Nna1-WT2. RT-PCR analysis conﬁrmed0
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Fig. 1. Genotyping strategy for detection of Nna1 BAC transgene-positive—pcd5J homoz
mice from pcd5J heterozygous mice (and non-pcdmutant mice), we performed quantitativ
containing the pcd5J insertion mutation sequence (red text). (B) Representative quantitat
DNA PCR analysis on tail DNA’s from a set of controls (+/+; 5J/+; and 5J/5J) and a set of unk
the known pcd5J heterozygous mouse. Based upon this analysis, we were able to assign w
status to mice 4 and 5. (C) Determination of Nna1 BAC transgene status. Here we see a rep
of a BAC vector-speciﬁc amplicon was performed, and detection of a signal indicated tha
no DNA template and served as the negative control, while lane 2 corresponds to BAC DN
are Nna1 BAC transgene-positive.increased expression of murine Nna1 at levels 150–200% of
non-transgenic control mice (data not shown). We thus selected
the higher expressing Nna1-WT1 line for directed breeding exper-
iments with pcd5J mice. To derive pcd5J homozygous mice carrying
the Nna1-WT1 BAC transgene, we crossed Nna1-WT1 BAC mice
with pcd5J homozygous female mice and then backcrossed pcd5J
heterozygous—Nna1 WT1 transgene-positive males with pcd5J
homozygous female mice. To identify pcd5J homozygous mice car-
rying the Nna1-WT1 BAC transgene, we developed a real-time PCR
approach to quantify pcd5J allele dosage (Fig. 1), and combined this
genotyping strategy with a standard PCR-based assay for BAC vec-
tor-speciﬁc sequences. In this way, we conﬁrmed the derivation of
Nna1-WT1 BAC transgene-positive, pcd5J homozygous mice.
3.2. The Nna1 BAC transgene rescues both Purkinje cell and retinal
degeneration in pcd mice
Adult pcd5J homozygous mice undergo a profound degeneration
and loss of Purkinje cell neurons in the cerebellum by seven weeks
of age. To determine if expression of the Nna1-WT1 BAC was
sufﬁcient to rescue this dramatic Purkinje cell degeneration, we
obtained cerebellar sections from 4-month-old littermate pcd5J
homozygous mice that were either positive or negative for the
Nna1-WT1 transgene. Calbindin immunostaining revealed a com-
plete rescue of Purkinje cell degeneration in Nna1-WT1 BAC trans-
gene-positive, pcd5J homozygous mice (Fig. 2A).
Analysis of home cage behavior similarly indicated that while
all pcd5J homozygous mice lacking the Nna1-WT1 BAC transgene5432
9876
ygous mice. (A) Quantitative PCR primer design. To differentiate pcd5J homozygous
e DNA PCR for an amplicon containing the pcd5Jmutation with a pcd5J-speciﬁc probe
ive DNA PCR genotyping results. Here we see the results of a quantitative real-time
nowns (1–5). 5J gene dosage was normalized to b-actin, and arbitrarily set to 1.0 for
ild-type status to mouse 1, heterozygous status to mice 2, and 3, and homozygous
resentative set of genotyping results for the Nna1 BAC transgene. PCR ampliﬁcation
t the mouse was Nna1 BAC transgene-positive. In this experiment, lane 1 contained
A template and served as the positive control. As shown here, individuals 6, 8, and 9
Fig. 2. The Nna1-WT1 BAC transgene rescues both Purkinje cell degeneration and retinal photoreceptor cell degeneration. (A–C) Cerebellar sections from 4-month-old Nna1-
WT1 BAC—pcd5J homozygous mice, pcd5J homozygous mice, and wild-type littermate mice were immunostained with an anti-calbindin antibody (green) and counter-stained
with DAPI. Both wild-type mice (A) and Nna1-WT1 BAC—pcd5J homozygous mice (B) exhibited a normal number of Purkinje cell neurons, comparable molecular layer (ML)
thickness, and prominent Purkinje cell dendritic arborization in the ML. Cerebellar sections from pcd5J homozygous mice (C), however, revealed a dramatic and total loss of
Purkinje cell neurons. GCL, granule cell layer; PCL, Purkinje cell layer; ML, molecular layer (D–F) Retinal sections from identical regions of the retina were obtained from 8-
month-old Nna1-WT1 BAC—pcd5J homozygous mice, pcd5J homozygous mice, and wild-type littermate mice, and were analyzed by Richardson’s staining. As shown here,
wild-type littermate mice (D) and Nna1-WT1 BAC—pcd5J homozygous mouse (E) displayed normal retinal cytoarchitecture and normal photoreceptor nuclei number in the
outer nuclear layer (ONL), with 10–12 photoreceptor nuclei across. Retinal sections from pcd5J homozygous mice (F) revealed a signiﬁcant thinning of the ONL, with as few as
ﬁve retinal photoreceptor nuclei adjacent in cross section. OS, outer segments; IS, inner segments; ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform
layer; GCL, ganglion cell layer.
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gene-positive, pcd5J homozygous mice were indistinguishable from
normal controls. Indeed, to date, we have generated over 30 litters
of Nna1-WT1 BAC—pcd5J mice, and not a single Nna1-WT1 BAC
transgene-positive, pcd5J homozygous mouse has ever displayed
any visible signs of ataxia. Rescued pcd5J male mice also were able
to successfully reproduce, siring normal-sized litters, though our
breeding studies of the pcd5J strain found that male sterility is
not fully penetrant for the 5J mutation (data not shown).
Although Nna1 transgenic expression directed to Purkinje cells
has been shown to be capable of rescuing pcd cerebellar degener-
ation, Wang, Parris, Li, and Morgan (2006), the necessity and sufﬁ-
ciency of Nna1 expression for preventing pcd retinal degeneration
is yet to be assessed. Our Nna1-WT1 BAC transgenic crosses with
pcd5J mice allowed us to address this question. As pcd retinal
degeneration is much more slowly progressive than the cerebellar
degeneration, we examined the effect of Nna1 transgene expres-
sion in 8-month-old littermate pcd5J homozygous mice that were
either positive or negative for the Nna1-WT1 BAC transgene. Stain-
ing of retinal sections from such litters revealed marked thinning
of the outer nuclear photoreceptor layer as well as degenerating
outer segments in pcd5J homozygous mice lacking the Nna1-WT1
BAC transgene (Fig. 2B). However, in all cases, Nna1-WT1 BAC
transgene-positive, pcd5J homozygous mice exhibited normal reti-
nal cytoarchitecture, comparable to the histological appearance
of non-transgenic controls (Fig. 2B). Thus, Nna1 BAC transgenic
expression does also rescue the pcd retinal degeneration
phenotype.
3.3. Engineering a zinc-binding deﬁcient Nna1 BAC transgene
After demonstrating that we could successfully rescue the key
neurodegenerative phenotypes of the pcd5J mouse with an Nna1
BAC transgene, we next turned our attention to an evaluation ofthe role of Nna1’s postulated carboxypeptidase activity in the pcd
phenotype. Alignment of the amino acid coding sequence of
Nna1 with related proteins has shown that murine Nna1 possesses
a highly-conserved zinc carboxypeptidase (ZnCP) domain, Harris
et al. (2000). Analysis of the Nna1 protein sequence reveals the
presence of multiple protein motifs and domains (Fig. 3). Indeed,
Nna1 contains an aspartic acid rich domain starting at amino acid
314 and ending at amino acid 402, an ATP binding domain span-
ning amino acids 810–817, whence the gene gets its ofﬁcial name
as ‘ATP and GTP binding protein 1 (Agtpbp1)0, a carboxy-terminal
bipartite nuclear localization signal at amino acid position 1011–
1015, and, ﬁnally, the ZnCP domain. Nna1’s region of peptidase se-
quence similarity extends from amino acid 851 to position 1075
(Fig. 4). Within this well-recognized motif, key conserved residues
reside, including a HXXE consensus at position 912–915 that is re-
quired for zinc binding and catalytic activity, Abe, Abe, Aoki, Itoy-
ama, and Tamai (1997). Given the absolute requirement for a
histidine at position 912 and a glutamic acid at position 915 for
putative zinc coordination and Nna1 ZnCP activity, we chose to
introduce point mutations at these two residues to change both
to alanine codons in the Nna1 BAC, using a standard BAC recomb-
ineering strategy Hegde and Paulson (2004) .We designated the
resulting BAC as the Nna1-MuZn BAC to denote its mutant zinc-
binding status.
3.4. Zinc-binding deﬁcient Nna1 protein fails to rescue Purkinje cell or
retinal degeneration in pcd mice
To determine if zinc coordination and presumably ZnCP enzy-
matic activity are required for -Nna1 genetic rescue of the pcd phe-
notype, we derived Nna1-MuZn BAC transgenic mice. RT-PCR
analysis of two independent Nna1-MuZn BAC lines (Nna1-MuZn1
and Nna1-MuZn2) indicated that transgene-positive mice from
these two lines, respectively, exhibit Nna1 expression levels at
Fig. 3. Nna1 functional domain analysis highlights key residues for zinc-binding
and putative enzymatic function. Here we see the amino acid sequence for mouse
Nna1. Green lettering denotes the aspartic acid rich domain starting at positions
314–402, pink lettering corresponds to the ATP binding domain. The highly
conserved carboxypeptidase domain is underlined, while the entire enzymatic
domain is indicated by bold lettering. Gray lettering demarcates the region of
aspartoacylase sequence similarity, with various key residues for enzymatic activity
indicated variously in red, blue, orange, or purple. The HXXE zinc-binding site is
shown with the invariant ‘H’ and ‘E’ residues in red. These residues were selected
for mutagenesis in the Nna1 BAC construct.
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Fig. 5. Failure of Nna1-MuZn2 BAC transgenic rescue of pcd phenotype can not be
attributed to inadequate Nna1 transgene expression. Western blot analysis of
cerebellar protein lysates immunoblotted with an anti-Nna1 antibody was
performed on samples obtained from different types of transgenic/pcd5J mice as
indicated above the four lanes. Nna1 protein expression in Nna1-MuZn2 BAC—pcd5J
homozygous mice were comparable to the level of Nna1 protein expression in pcd5J
heterozygous mice that are normal. Immunoblots were re-probed with an anti
b-actin antibody as a loading control.
L. Chakrabarti et al. / Vision Research 48 (2008) 1999–2005 2003140–180% of non-transgenic wild-type mice. We thus selected the
Nna1-MuZn2 BAC transgenic line for cross-breeding experiments
with pcd5J homozygous mice. Using the PCR genotyping strategy
described above, we identiﬁed pcd5J homozygous mice that either
lacked the Nna1-MuZn2 BAC transgene or were positive for theFig. 4. The Nna1-MuZn2 BAC transgene fails to prevent either Purkinje cell degeneratio
Nna1-MuZn2 BAC—pcd5J homozygous mice, pcd5J homozygous mice, and wild-type lit
counter-stained with DAPI. Wild-type mice (A) had a normal number of Purkinje cell
dendritic arborization in the ML. Cerebellar sections from Nna1-MuZn2 BAC—pcd5J homo
loss of Purkinje cell neurons. (D–F) Retinal sections from identical regions of the retina
homozygous mice, and wild-type littermate mice, and were analyzed by Richardson’s
cytoarchitecture and normal photoreceptor nuclei number in the outer nuclear layer (O
BAC—pcd5J homozygous mice (E) and pcd5J homozygous mice (F) revealed a signiﬁcant tNna1-MuZn2 BAC transgene. When we compared Nna1-MuZn2
BAC transgene-positive pcd5J homozygous mice with pcd5J homo-
zygous mice littermates that did not possess the Nna1-MuZn2
BAC transgene, we noted that transgene-positive and transgene-
negative pcd5J homozygous mice both displayed gait ataxia at the
time of weaning. In agreement with our behavioral analysis, cal-
bindin immunostaining of Nna1-MuZn2 BAC transgene-positiven or retinal degeneration in pcd mice. (A–C) Cerebellar sections from 4-month-old
termate mice were immunostained with an anti-calbindin antibody (green) and
neurons, comparable molecular layer (ML) thickness, and prominent Purkinje cell
zygous mice (B) and pcd5J homozygous mice (C), however, both revealed a complete
were obtained from 8-month-old Nna1-MuZn2 BAC—pcd5J homozygous mice, pcd5J
staining. As shown here, wild-type littermate mice (D) exhibited normal retinal
NL), with 10–12 photoreceptor nuclei across. Retinal sections from Nna1-MuZn2
hinning of the ONL. Abbreviations are as in Fig. 2.
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pattern of Purkinje cell loss that was indistinguishable from trans-
gene-negative pcd5J homozygous mice (Fig. 4A). Furthermore, eval-
uation of retinal sections obtained from Nna1 MuZn2 BAC
transgene-positive pcd5J homozygous mice revealed substantial
thinning of the outer nuclear layer and outer segment disorganiza-
tion, kin to the appearance of the retina in transgene-negative pcd5J
homozygous mice (Fig. 4B). Thus, based upon behavioral and histo-
logical analysis, the presence of the Nna1-MuZn2 BAC transgene
did not ameliorate pcd retinal and cerebellar degeneration. To en-
sure that the failure of the Nna1-MuZn2 BAC transgene to rescue
the pcd5J phenotype could not be attributed to inadequate Nna1
protein expression from the BAC transgene, we performedWestern
blot analysis on cerebellar protein lysates from rescued Nna1-WT1
BAC pcd5J homozygous mice, Nna1-MuZn2 BAC transgene-positive
pcd5J homozygous mice, pcd5J homozygous mice, and pcd5J hetero-
zygous mice (Fig. 5). Nna1 immunoblotting conﬁrmed that Nna1-
MuZn2 BAC transgene-positive pcd5J homozygous mice express
Nna1 protein at levels comparable to Nna1-pcd5J heterozygous
mice. As pcd5J heterozygotes do not display any signs of retinal
or cerebellar disease, the failure of the Nna1-MuZn2 BAC transgene
to rescue the pcd5J phenotype indicates that a functional zinc coor-
dination domain is required for Nna1 rescue.4. Discussion
Concomitant degeneration of the cerebellum and the retina is a
feature of numerous human diseases, including spinocerebellar
ataxia type 7, neuronal ceroid lipofuscinosis, and Joubert syn-
drome, Lindhout, Barth, Valk, and Boen-Tan (1980), Luiro, Kopra,
Lehtovirta, and Jalanko (2001), Yvert et al. (2000). In mice, various
spontaneous mutant strains similarly display progressive cerebel-
lar and retinal degeneration, including nervous, harlequin, and Pur-
kinje cell degeneration (pcd) Mullen et al. (1976), LaVail et al.
(1993), Vaishnav et al. (2008). For this reason, fundamental pro-
cesses of neuron development and neuron survival are likely to
be shared between the cerebellum and retina, providing an oppor-
tunity to delineate such pathways by comparative analysis of the
molecular basis of cerebellar and retinal degeneration involving
such mutations. In this study, we considered the genetic and
molecular basis of pcd, an autosomal recessive mouse mutant that
exhibits a stereotypical phenotype of Purkinje cell degeneration
and retinal degeneration, Mullen et al. (1976). Previous work iden-
tiﬁed mutations in a relatively novel gene, Nna1, and demon-
strated that Nna1 loss-of-function accounts for the cerebellar
degeneration, Wang et al. (2006), but an exclusive role for Nna1
loss-of-function in pcd cerebellar and retinal degeneration had
not been established. Our results indicate that transgenic rescue
of pcd5J mice with a BAC containing the Nna1 gene with generous
50 and 30 ﬂanking regions is sufﬁcient to rescue pcd retinal degen-
eration as well as the Purkinje cell loss and ataxia phenotype, and
lend further credence to the view that Nna1 loss-of-function is
alone responsible for the diverse phenotypes observed in pcd null
mice.
One of the most intriguing questions stemming from our stud-
ies of pcd is the functional basis of Nna1 action in promoting neu-
ron survival in cerebellar Purkinje cells and retinal photoreceptors.
Nna1 is part of an extensive family of genes, all of which contain a
highly conserved zinc-dependent carboxypeptidase (ZnCP) do-
main, Rodriguez de la Vega et al. (2007). Recently, ﬁve additional
Nna1-like genes were identiﬁed in the mouse genome and desig-
nated cytosolic carboxypeptidases (CCP2—6), Rodriguez de la Vega
et al. (2007).
Modeling algorithms indicated that the folding of these proteins
resembles the M14 family of carboxypeptidases, with theoreticallymatching residues for activity and substrate speciﬁcity. All the
CCPs are abundant in testis and are also expressed in the brain,
pituitary, and eye, Rodriguez de la Vega et al. (2007). Whether or
not these mammalian CCPs and Nna1 retain ZnCP enzymatic activ-
ity remains unclear, as biochemical studies in our lab and by an-
other group are yet to document carboxypeptidase activity, even
though a wide variety of carboxy-terminal residues were tested
(data not shown), Wang et al. (2006). However, a recombinant
form of one Nna1-like peptidase from Caenorhabditis elegans was
shown to be a fully functional carboxypeptidase, Rodriguez de la
Vega et al. (2007). The enzymatic activity of this protein required
ATP/ADP and was inactivated by high salt concentrations, Rodri-
guez de la Vega et al. (2007). The amino acid sequence of mouse
Nna1 has sufﬁcient sequence similarity to theoretically assign it
a functional asparto-acylase domain (BLASTP, NCBI). Nna1 also
contains an ATP/GTP binding domain in the central portion of its
predicted amino acid coding sequence, Harris et al. (2000).While
these motif and enzymatic predictions suggest likely activities for
Nna1, the true function(s) of Nna1 remains to be elucidated. Future
studies aimed at understanding how Nna1 loss-of-function ulti-
mately leads to cerebellar Purkinje cell degeneration and retinal
photoreceptor degeneration will need to uncover the function of
Nna1, before the mechanistic basis of pcd neuronal dysfunction
can be determined. As Nna1 normal function appears crucial for
both neuron survival and neuron regeneration, Harris et al.
(2000), Wang and Morgan (2007), important insights into normal
neuron function and injury recovery will undoubtedly emerge
from such work.
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